Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Solas

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
International Journal of Antimicrobial Agents|November 6, 2018
Drug-Drug Interactions Potential of Direct-Acting Antivirals for the treatment of Chronic Hepatitis C Virus infectionNadège Néant, Caroline Solas
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring of atazanavir]Caroline Solas, Patrice Muret,
Therapie|July 10, 2016
[Not Available]Patrice Muret, Caroline Solas,
Therapie|July 10, 2016
[Not Available]Caroline Solas, Patrice Muret,
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for saquinavir]Patrice Muret, Caroline Solas,
Therapie|July 10, 2016
[Not Available]Caroline Solas, Marie-Claude Gagnieu,
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for efavirenz]Caroline Solas, Marie-Claude Gagnieu,
Current Opinion in HIV and AIDS|August 7, 2015
Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfectionOmar El-Sherif, Saye Khoo, Caroline Solas
Clinics and Research in Hepatology and Gastroenterology|February 21, 2012
Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapyJulien Dupouey, René Gerolami, Caroline Solas, et al.
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for nevirapine]Patrice Muret, Sarah Piedoux, Caroline Solas, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Antimicrobial Agents|November 6, 2018
Drug-Drug Interactions Potential of Direct-Acting Antivirals for the treatment of Chronic Hepatitis C Virus infectionNadège Néant, Caroline Solas
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring of atazanavir]Caroline Solas, Patrice Muret,
Therapie|July 10, 2016
[Not Available]Patrice Muret, Caroline Solas,
Therapie|July 10, 2016
[Not Available]Caroline Solas, Patrice Muret,
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for saquinavir]Patrice Muret, Caroline Solas,
Therapie|July 10, 2016
[Not Available]Caroline Solas, Marie-Claude Gagnieu,
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for efavirenz]Caroline Solas, Marie-Claude Gagnieu,
Current Opinion in HIV and AIDS|August 7, 2015
Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfectionOmar El-Sherif, Saye Khoo, Caroline Solas
Clinics and Research in Hepatology and Gastroenterology|February 21, 2012
Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapyJulien Dupouey, René Gerolami, Caroline Solas, et al.
Therapie|August 9, 2011
[Evidence-based therapeutic drug monitoring for nevirapine]Patrice Muret, Sarah Piedoux, Caroline Solas, et al.
Pageof 13